|
Search
Collections
Benchmarks
Upload document
Product
JS203
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial
Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Status: Recruiting
, Estimated PCD: 2024-12-24
